• For Researchers

Dave Sims: A family uniting against cancer

Mark Sims was 15 when he was first diagnosed with melanoma in 2003. Here, his brother Dave shares Mark's story of how he got involved in the PEACE study. Mark Sims was 15 when he was first diagnosed with melanoma in 2003. Here, his brother Dave shares Mark's story of how he got involved in the PEACE study.

20 June 2017

• For Researchers

Improving radiotherapy for brain cancers

A Q&A with Dr Ross Carruthers on DNA damage response mechanisms in glioblastoma, and why these cancers are particularly resistant to radiotherapy. A Q&A with Dr Ross Carruthers on DNA damage response mechanisms in glioblastoma, and why these cancers are particularly resistant to radiotherapy.

20 June 2017

• For Researchers

Hacking into normality: Gerard Evan

An interview with Gerard Evan on a new way of viewing pancreatic and lung cancer and the implications for understanding the disease, and how to treat it. An interview with Gerard Evan on a new way of viewing pancreatic and lung cancer and the implications for understanding the disease, and how to treat it.

20 June 2017

• For Researchers

Tackling hard-to-treat cancers from every angle

Improving the quality and quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of our research activity. Improving the quality and quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of our research activity.

20 June 2017

• For Researchers

Behind the scenes: pioneering human stem cell research

In 2016 Dr Kathy Niakan became the first person in the world to gain regulatory approval to edit the genomes of human embryos for research. In 2016 Dr Kathy Niakan became the first person in the world to gain regulatory approval to edit the genomes of human embryos for research.

20 June 2017

• For Researchers

A mixing pot of ideas: world-class immunology

Professor Caetano Reis e Sousa on the move into the Francis Crick Institute, where he is a group leader, and the work currently going on in his lab. Professor Caetano Reis e Sousa on the move into the Francis Crick Institute, where he is a group leader, and the work currently going on in his lab.

20 June 2017

• For Researchers

Open for business: inside the Francis Crick Institute

The Crick is now home to 1,250 scientists and 250 support staff. Take a look behind the doors of the biggest biomedical research facility in Europe. The Crick is now home to 1,250 scientists and 250 support staff. Take a look behind the doors of the biggest biomedical research facility in Europe.

20 June 2017

• For Researchers

How our fellowships make a difference

Our fellowship schemes are designed to support long-term career progression, supporting home-grown talent and promising scientists from around the world. Our fellowship schemes are designed to support long-term career progression, supporting home-grown talent and promising scientists from around the world.

20 June 2017

• For Researchers

Measuring the impact of research

What is the best way to evaluate the broader societal impact of research? Enter the world of research impact assessment. What is the best way to evaluate the broader societal impact of research? Enter the world of research impact assessment.

20 June 2017

• For Researchers

Recognising excellence: our 2016 prizewinners

CRUK's research prizes recognise and celebrate outstanding and innovative cancer researchers. CRUK's research prizes recognise and celebrate outstanding and innovative cancer researchers.

20 June 2017

• For Researchers

Catching cancer earlier: a new frontier for early detection research

We are investing in early detection and diagnosis research: building capacity, forging partnerships, and supporting an early detection research community. We are investing in early detection and diagnosis research: building capacity, forging partnerships, and supporting an early detection research community.

20 June 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017